Inactive Instrument
Eurofins-Cerep Stock Euronext Paris
Stocks
FR0012413771
Biotechnology & Medical Research
| Market Cap | 91.3M 102M 85.06M 77.4M 146M 9.86B 147M 1.03B 400M 5.03B 384M 376M 16.17B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 70.26M 78.76M 65.46M 59.57M 112M 7.59B 113M 791M 308M 3.87B 296M 289M 12.44B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.01% |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 11/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 11/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 23/05/2024 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +4,900.50% | - | - | 102M | |
| +4.16% | +3.42% | +49.37% | +94.17% | 74.31B | |
| +1.53% | -2.76% | +21.36% | +76.43% | 56.95B | |
| +0.19% | -1.47% | +3.27% | +34.13% | 48.3B | |
| -4.34% | -3.61% | +323.12% | +687.10% | 44.51B | |
| -1.16% | -1.88% | +28.74% | +32.87% | 43.8B | |
| +0.69% | -0.79% | +5.18% | +108.40% | 41.12B | |
| -0.54% | +2.41% | +9.31% | +58.85% | 31.07B | |
| +4.51% | +8.22% | +37.86% | +32.49% | 28.97B | |
| -0.10% | -2.21% | -8.34% | -13.33% | 24.53B | |
| Average | +0.51% | -0.04% | +52.21% | +123.46% | 43.73B | |
| Weighted average by Cap. | +0.77% | -0.31% | +56.10% | +131.93% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 45.38M 37.72M 34.33M 64.64M 4.37B 65.12M 456M 177M 2.23B 170M 167M 7.17B | 41.1M 46.07M 38.29M 34.84M 65.62M 4.44B 66.11M 463M 180M 2.26B 173M 169M 7.28B |
| Net income | 7.15M 8.02M 6.67M 6.07M 11.42M 772M 11.51M 80.54M 31.34M 394M 30.11M 29.46M 1.27B | 4.78M 5.36M 4.46M 4.05M 7.64M 516M 7.69M 53.84M 20.95M 264M 20.12M 19.69M 847M |
| Net Debt | -17.25M -19.34M -16.07M -14.63M -27.55M -1.86B -27.75M -194M -75.56M -951M -72.6M -71.04M -3.06B | -21.03M -23.58M -19.6M -17.83M -33.58M -2.27B -33.83M -237M -92.13M -1.16B -88.52M -86.61M -3.73B |
Employees
-
